Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation (Q40336251)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 December 2005

Language	Label	Description	Also known as
English	Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation	scientific article published on 23 December 2005

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation (English)

1 reference

Europe PubMed Central

19 September 2017

Ann Gillenwater

2

object named as

Ann Gillenwater

1 reference

Europe PubMed Central

19 September 2017

author name string

Yasunari Takada

1

1 reference

Europe PubMed Central

19 September 2017

Haruyo Ichikawa

3

1 reference

Europe PubMed Central

19 September 2017

Bharat B Aggarwal

4

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

23 December 2005

1 reference

Europe PubMed Central

19 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

19 September 2017

281

1 reference

Europe PubMed Central

19 September 2017

9

1 reference

Europe PubMed Central

19 September 2017

5612-5622

1 reference

Europe PubMed Central

19 September 2017

Histone deacetylases and cancer: causes and therapies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Signalling pathways of the TNF superfamily: a double-edged sword

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Sensitizes Macrophages to Lipopolysaccharide-induced Nuclear Factor-κB, Mitogen-activated Protein Kinases, and Apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1,

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Role of collagenases in tumor cell invasion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Missing pieces in the NF-kappaB puzzle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Mechanisms by which IkappaB proteins control NF-kappaB activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Nuclear transcription factor-kappaB as a target for cancer drug development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Histone deacetylases augment cytokine induction of the iNOS gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Duration of nuclear NF-kappaB action regulated by reversible acetylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Differential IκB Kinase Activation and IκBα Degradation by Interleukin-1β and Tumor Necrosis Factor-α in Human U937 Monocytic Cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507213200

21 January 2018

Identifiers

10.1074/JBC.M507213200

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40336251&oldid=1895568331"